PPH Holdings
27 holdings in the fund's latest file; the data source updated it on Oct 8, 2026.
Top 25 Holdings
| # | Holding | Weight | Shares (as reported) | Value (as reported) |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 20.93% | 183,661 | $212.6M |
| 2 | Merck & Co Inc | 13.15% | 941,328 | $133.6M |
| 3 | Novo Nordisk A/S | 5.61% | 1,517,037 | $56.9M |
| 4 | Pfizer Inc | 5.03% | 1,858,109 | $51.1M |
| 5 | Teva Pharmaceutical Industries Ltd (TEVA) | 4.75% | 1,232,549 | $48.2M |
| 6 | Mckesson Corp | 4.73% | 52,102 | $48.0M |
| 7 | Bristol-Myers Squibb Co | 4.70% | 801,401 | $47.8M |
| 8 | Cencora Inc | 4.48% | 143,683 | $45.5M |
| 9 | Gsk Plc | 4.38% | 955,307 | $44.5M |
| 10 | Abbvie Inc | 3.74% | 142,358 | $38.0M |
| 11 | Haleon Plc | 3.68% | 4,211,381 | $37.4M |
| 12 | Novartis Ag | 3.60% | 259,818 | $36.6M |
| 13 | Astrazeneca Plc | 3.55% | 227,602 | $36.1M |
| 14 | Johnson & Johnson | 3.35% | 133,740 | $34.1M |
| 15 | Sanofi Sa/France | 3.25% | 833,593 | $33.0M |
| 16 | Takeda Pharmaceutical Co Ltd | 2.73% | 1,530,786 | $27.7M |
| 17 | Zoetis Inc | 2.55% | 363,458 | $25.9M |
| 18 | Viatris Inc | 1.50% | 869,598 | $15.3M |
| 19 | Jazz Pharmaceuticals Plc | 1.33% | 58,543 | $13.5M |
| 20 | Corcept Therapeutics Inc | 0.81% | 68,604 | $8.2M |
| 21 | Axsome Therapeutics Inc | 0.70% | 40,820 | $7.1M |
| 22 | Elanco Animal Health Inc | 0.50% | 228,068 | $5.1M |
| 23 | Definium Therapeutics Inc | 0.46% | 131,653 | $4.7M |
| 24 | Organon & Co | 0.29% | 216,367 | $3.0M |
| 25 | Perrigo Co Plc | 0.10% | 74,159 | $1.0M |
Sector Weights
- Healthcare: 100.00%
Country Weights
- United States: 66.97%
- United Kingdom: 11.60%
- Denmark: 5.58%
- Israel: 4.80%
- Switzerland: 3.61%
- France: 3.28%
- Japan: 2.69%
- Ireland: 1.36%
- Other: 0.10%
Shares, value and weight are as reported in the file, dated by the data source's last update of it (not the date of the positions), never adjusted; a split warning appears only for a split close to or after that date, and its absence does not mean the count is on today's share basis. Weights as the fund reports them. Leveraged and inverse funds list swaps and cash, so weights can be negative or add up past 100.